about
Factors associated with appointment non-adherence among African-Americans with severe, poorly controlled hypertension.On the CUSP: Stop BSI: evaluating the relationship between central line-associated bloodstream infection rate and patient safety climate profile.Reducing medical errors and adverse events.Reducing preventable harm: observations on minimizing bloodstream infections.Maintaining and sustaining the On the CUSP: stop BSI model in Hawaii.Evaluation of Patient and Family Engagement Strategies to Improve Medication Safety.Associations between home remedy use and a validated self-reported adherence measure in an urban African-American population with poorly controlled hypertension.Access to Care, Treatment Ambivalence, Medication Nonadherence, and Long-Term Mortality Among Severely Hypertensive African Americans: A Prospective Cohort Study.Evaluating the impact of mandatory public reporting on participation and performance in a program to reduce central line-associated bloodstream infections: evidence from a national patient safety collaborative.Impact of self-reported guideline compliance: Bloodstream infection prevention in a national collaborative.Using the Opportunity Estimator tool to improve engagement in a quality and safety intervention.Executive/Senior Leader Checklist to improve culture and reduce central line-associated bloodstream infections.Decreasing central-line-associated bloodstream infections in Connecticut intensive care units.Using evidence, rigorous measurement, and collaboration to eliminate central catheter-associated bloodstream infections.Eliminating central line-associated bloodstream infections: a national patient safety imperative.
P50
Q34046560-732981FF-D508-4CB1-A8FD-52AC54CA66D5Q35817757-82044F38-BE11-41FC-9575-2C21991CD3EDQ37952767-1B43AB2B-8759-40B6-BF85-6C7FFFFB4639Q38372584-94648CE6-F9A2-4611-8A7A-49BA892D8D18Q38565887-9106722C-68E9-4A6C-89C0-FFD3459AB6D1Q38631116-8BA9F8D2-E020-4FDA-B516-3666E1F9E35AQ39834781-7A70057E-5073-480A-9D80-C298DB4EE0C6Q40276460-C06E1C0A-1967-4B1E-8784-4AD479AD75EEQ41732444-7DAF63E8-F422-4582-86FC-F82781F0BBEAQ41732461-37E0EA92-0ABE-43BB-822F-E44475848717Q44121970-1A69A019-4014-41A9-AC31-A2410628AC41Q44222799-256B7B9B-167C-4616-9E56-63A3995EBA8FQ44498667-9BA02F12-AB8A-4877-85DC-9074E69342C0Q46425706-7DEF7A82-69A0-4CD9-A6A7-A311982690AEQ54445483-2D3A3DB8-47A4-4DBD-9ABE-3D6C6BD429CA
P50
name
Kristina Weeks
@en
type
label
Kristina Weeks
@en
prefLabel
Kristina Weeks
@en